-
2
-
-
0030034518
-
United Kingdom Prospective Diabetes Study 17: A 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus
-
Turner R, Cull C, Holman R: United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med 124:136-145, 1996
-
(1996)
Ann Intern Med
, vol.124
, pp. 136-145
-
-
Turner, R.1
Cull, C.2
Holman, R.3
-
3
-
-
0029099086
-
Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus
-
DeFronzo RA, Goodman AM, Multicenter Metformin Study Group: Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 333:541-549, 1995
-
(1995)
N Engl J Med
, vol.333
, pp. 541-549
-
-
DeFronzo, R.A.1
Goodman, A.M.2
-
4
-
-
0030317624
-
Pharmacologic treatment options for non-insulin-dependent diabetes mellitus
-
Tan GH, Nelson RL: Pharmacologic treatment options for non-insulin-dependent diabetes mellitus. Mayo Clin Proc 71:763-768, 1996
-
(1996)
Mayo Clin Proc
, vol.71
, pp. 763-768
-
-
Tan, G.H.1
Nelson, R.L.2
-
5
-
-
0030044554
-
Efficacy of metformin in non-insulin-dependent diabetes mellitus
-
Gueriguian J, Green L, Misbin RI, Stadel B, Fleming GA: Efficacy of metformin in non-insulin-dependent diabetes mellitus (Letter). N Engl J Med 334:269-270, 1996
-
(1996)
N Engl J Med
, vol.334
, pp. 269-270
-
-
Gueriguian, J.1
Green, L.2
Misbin, R.I.3
Stadel, B.4
Fleming, G.A.5
-
6
-
-
0031053808
-
An overview of metformin in the treatment of type 2 diabetes mellitus
-
Davidson MB, Peters AL: An overview of metformin in the treatment of type 2 diabetes mellitus. Am J Med 102:99-110, 1997
-
(1997)
Am J Med
, vol.102
, pp. 99-110
-
-
Davidson, M.B.1
Peters, A.L.2
-
7
-
-
0030764041
-
The excess costs of medical care for patients with diabetes mellitus in a managed care population
-
Selby JV, Ray GT, Zhang D, Colby CJ: The excess costs of medical care for patients with diabetes mellitus in a managed care population. Diabetes Care 20:1396-1402, 1997
-
(1997)
Diabetes Care
, vol.20
, pp. 1396-1402
-
-
Selby, J.V.1
Ray, G.T.2
Zhang, D.3
Colby, C.J.4
-
8
-
-
0031964322
-
UKPDS 28: A randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 patients
-
U.K. Prospective Diabetes Study Group: UKPDS 28: a randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 patients. Diabetes Care 21:87-92, 1998
-
(1998)
Diabetes Care
, vol.21
, pp. 87-92
-
-
-
9
-
-
0028034406
-
Antihyperglycaemic efficacy, response prediction and dose-response relations of treatment with metformin and sulphonylurea, alone and in primary combination
-
Hermann LS, Schersten B, Melander A: Antihyperglycaemic efficacy, response prediction and dose-response relations of treatment with metformin and sulphonylurea, alone and in primary combination. Diabet Med 11:953-960, 1994
-
(1994)
Diabet Med
, vol.11
, pp. 953-960
-
-
Hermann, L.S.1
Schersten, B.2
Melander, A.3
-
10
-
-
0027411979
-
Metformin for obese, insulin-treated diabetic patients: Improvement in glycaemic control and reduction of metabolic risk factors
-
Giugliano D, Quatraro A, Consoli G, Minei A, Ceriello A, DeRosa N, D'Onofrio F: Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors. Eur J Clin Pharmacol 44:107-112, 1993
-
(1993)
Eur J Clin Pharmacol
, vol.44
, pp. 107-112
-
-
Giugliano, D.1
Quatraro, A.2
Consoli, G.3
Minei, A.4
Ceriello, A.5
DeRosa, N.6
D'Onofrio, F.7
-
11
-
-
0000504298
-
The effects of metformin in poorly controlled insulin-treated type 2 diabetes mellitus
-
Aviles-Santa L, Sinding J, Raskin P: The effects of metformin in poorly controlled insulin-treated type 2 diabetes mellitus (Abstract). Diabetes 47 (Suppl. 1):A89, 1998
-
(1998)
Diabetes
, vol.47
, Issue.1 SUPPL.
-
-
Aviles-Santa, L.1
Sinding, J.2
Raskin, P.3
-
12
-
-
0002295222
-
Advantages of adding metformin to multiple dose insulin therapy in type 2 diabetes
-
Bergenstal R, Johnson M, Whipple D, Noller D, Boyce K, Roth L, Upham P, Fish L, Debold R: Advantages of adding metformin to multiple dose insulin therapy in type 2 diabetes (Abstract). Diabetes 47 (Suppl. 1):A89, 1998
-
(1998)
Diabetes
, vol.47
, Issue.1 SUPPL.
-
-
Bergenstal, R.1
Johnson, M.2
Whipple, D.3
Noller, D.4
Boyce, K.5
Roth, L.6
Upham, P.7
Fish, L.8
Debold, R.9
-
13
-
-
0029103037
-
Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: A study of a United Kingdom population
-
Jones JK, Gorkin L, Lian JF, Staffa JA, Fletcher AP: Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. BMJ 311:293-299, 1995
-
(1995)
BMJ
, vol.311
, pp. 293-299
-
-
Jones, J.K.1
Gorkin, L.2
Lian, J.F.3
Staffa, J.A.4
Fletcher, A.P.5
-
14
-
-
0027432702
-
Temporal patterns of antihypertensive medication use among elderly patients: The Cardiovascular Health Study
-
Psaty BM, Savage JP, Tell GS, Polak JF, Hirsch CH, Gardin JM, McDonald RH Jr: Temporal patterns of antihypertensive medication use among elderly patients: the Cardiovascular Health Study. JAMA 270:1837-1841, 1993
-
(1993)
JAMA
, vol.270
, pp. 1837-1841
-
-
Psaty, B.M.1
Savage, J.P.2
Tell, G.S.3
Polak, J.F.4
Hirsch, C.H.5
Gardin, J.M.6
McDonald R.H., Jr.7
-
15
-
-
0032513736
-
Persistence of use of lipid-lowering medications: A cross-national study
-
Avorn J, Monette J, Lacour A, Bohn RL, Monone M, Moqun H, LeLorier J: Persistence of use of lipid-lowering medications: a cross-national study. JAMA 279:1458-1462, 1998
-
(1998)
JAMA
, vol.279
, pp. 1458-1462
-
-
Avorn, J.1
Monette, J.2
Lacour, A.3
Bohn, R.L.4
Monone, M.5
Moqun, H.6
Lelorier, J.7
|